Crystalloids vs. colloids: KO at the twelfth round?

Critical Care

Volumn 17, Issue 3, 2013, Pages

  Phillips, Dennis P ^a   Kaynar, A Murat ^a   Kellum, John A ^a   Gomez, Hernando ^a  

^a UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CHLORINE; CREATININE; HETASTARCH; HETASTARCH DERIVATIVE;

ACUTE KIDNEY FAILURE; ADULT; ARTICLE; BRAIN HEMORRHAGE; CAUSE OF DEATH; COLLOID; CRYSTALLOID; DIALYSIS; DRUG EFFICACY; DRUG SAFETY; FLUID RESUSCITATION; GLOMERULUS FILTRATION RATE; HUMAN; INTENSIVE CARE UNIT; LIFE EXPECTANCY; MAJOR CLINICAL STUDY; MOLECULAR WEIGHT; MORTALITY; NEPHROTOXICITY; OUTCOME ASSESSMENT; PRIORITY JOURNAL; RENAL REPLACEMENT THERAPY; RISK FACTOR; TREATMENT FAILURE; TREATMENT OUTCOME; URINE VOLUME; CRITICAL ILLNESS; FEMALE; FLUID THERAPY; MALE; PROCEDURES;

CRITICAL ILLNESS; FEMALE; FLUID THERAPY; HUMANS; HYDROXYETHYL STARCH DERIVATIVES; MALE;

EID: 84878540156     PISSN: 13648535     EISSN: 1466609X     Source Type: Journal    
DOI: 10.1186/cc12708     Document Type: Article

References (10)

1. Finfer S, Bellomo R, Boyce N, French J, Myburgh J, Norton R, SAFE Study Investigators A comparison of albumin and saline for fluid resuscitation in the intensive care unit. N Engl J Med 2004, 350:2247-2256. SAFE Study Investigators.
2. Zarychanski R, Turgeon AF, Fergusson DA, Cook DJ, Hébert P, Bagshaw SM, Monsour D, McIntyre L. Renal outcomes and mortality following hydroxyethyl starch resuscitation of critically ill patients: systemic review and meta-analysis of randomized trials. Open Med 2009, 3:e196-e209. 3090114, 21688756.
3. Bunn F, Trivedi D, Ashraf S. Colloid solutions for fluid resuscitation. Cochrane Database Syst Rev 2008, CD001319.
4. Barron ME, Wilkes MM, Navickis RJ. A systematic review of the comparative safety of colloids. Arch Surg 2004, 139:552-563. 10.1001/archsurg.139.5.552, 15136357.
5. Wikes MM, Navickis RJ, Sibbald WJ. Albumin versus hydroxyethyl starch in cardiopulmonary bypass surgery: a meta-analysis of postoperative bleeding. Ann Thorac Surg 2001, 72:527-533. discussion 534, 10.1016/S0003-4975(01)02745-X, 11515893.
6. Myburgh J, Cooper DJ, Finfer S, Bellomo R, Norton R, Bishop N, Kai Lo S, Vallance S. SAFE Study Investigators, Australian and New Zealand Intensive Care Society Clinical Trials Group, Australian Red Cross Blood Service, George Institute for International Health Saline or albumin for fluid resuscitation in patients with traumatic brain injury. N Engl J Med 2007, 357:874-884. SAFE Study Investigators, Australian and New Zealand Intensive Care Society Clinical Trials Group, Australian Red Cross Blood Service, George Institute for International Health.
7. Brunkhorst FM, Engel C, Bloos F, Meier-Hellmann A, Ragaller M, Weiler N, Moerer O, Gruendling M, Oppert M, Grond S, Olthoff D, Jaschinski U, John S, Rossaint R, Welte T, Schaefer M, Kern P, Kuhnt E, Kiehntopf M, Hartog C, Natanson C, Loeffler M, Reinhart K, German Competence Network Sepsis (SepNet) Intensive insulin therapy and pentastarch resuscitation in severe sepsis. N Engl J Med 2008, 358:125-139. 10.1056/NEJMoa070716, 18184958, German Competence Network Sepsis (SepNet).
8. Perel P, Roberts I. Colloids versus crystalloids for fluid resuscitation in critically ill patients. Cochrane Database Syst Rev 2012, CD000567.
9. Perner A, Haase N, Guttormsen AB, Tenhunen J, Klemenzson G, Åneman A, Madsen KR, Møller MH, Elkjær JM, Poulsen LM, Bendtsen A, Winding R, Steensen M, Berezowicz P, Søe-Jensen P, Bestle M, Strand K, Wiis J, White JO, Thornberg KJ, Quist L, Nielsen J, Andersen LH, Holst LB, Thormar K, Kjældgaard AL, Fabritius ML, Mondrup F, Pott FC, Møller TP, Winkel P, Wetterslev J, , 6S Trial Group, Scandinavian Critical Care Trials Group Hydroxyethyl starch 130/0.42 versus Ringer's acetate in severe sepsis. N Engl J Med 2012, 367:124-134. 10.1056/NEJMoa1204242, 22738085, 6S Trial Group, Scandinavian Critical Care Trials Group.
10. Shaw AD, Kellum JA. The risk of AKI in patients treated with intravenous solutions containing hydroxyethyl starch. Clin J Am Soc Nephrol 2013, 8:497-503. 10.2215/CJN.10921012, 23335037.